158 related articles for article (PubMed ID: 14599482)
1. Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology.
Klingner M; Apelt J; Kumar A; Sorger D; Sabri O; Steinbach J; Scheunemann M; Schliebs R
Int J Dev Neurosci; 2003 Nov; 21(7):357-69. PubMed ID: 14599482
[TBL] [Abstract][Full Text] [Related]
2. Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein.
Apelt J; Kumar A; Schliebs R
Brain Res; 2002 Oct; 953(1-2):17-30. PubMed ID: 12384234
[TBL] [Abstract][Full Text] [Related]
3. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
4. Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.
Bigl M; Apelt J; Eschrich K; Schliebs R
J Neural Transm (Vienna); 2003 Jan; 110(1):77-94. PubMed ID: 12541014
[TBL] [Abstract][Full Text] [Related]
5. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.
Hu L; Wong TP; Côté SL; Bell KF; Cuello AC
Neuroscience; 2003; 121(2):421-32. PubMed ID: 14522000
[TBL] [Abstract][Full Text] [Related]
6. Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology.
Apelt J; Bigl M; Wunderlich P; Schliebs R
Int J Dev Neurosci; 2004 Nov; 22(7):475-84. PubMed ID: 15465277
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
8. Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice.
Gau JT; Steinhilb ML; Kao TC; D'Amato CJ; Gaut JR; Frey KA; Turner RS
Am J Pathol; 2002 Feb; 160(2):731-8. PubMed ID: 11839594
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein.
Liskowsky W; Schliebs R
Int J Dev Neurosci; 2006; 24(2-3):149-56. PubMed ID: 16423497
[TBL] [Abstract][Full Text] [Related]
10. Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice.
Lüth HJ; Apelt J; Ihunwo AO; Arendt T; Schliebs R
Brain Res; 2003 Jul; 977(1):16-22. PubMed ID: 12788508
[TBL] [Abstract][Full Text] [Related]
11. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
12. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.
Schliebs R; Arendt T
J Neural Transm (Vienna); 2006 Nov; 113(11):1625-44. PubMed ID: 17039298
[TBL] [Abstract][Full Text] [Related]
13. Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology.
Mehlhorn G; Hollborn M; Schliebs R
Int J Dev Neurosci; 2000; 18(4-5):423-31. PubMed ID: 10817926
[TBL] [Abstract][Full Text] [Related]
14. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
15. Neurotransmitters and energy metabolites in amyloid-bearing APP(SWE)xPSEN1dE9 Mouse Brain.
Hartmann J; Kiewert C; Klein J
J Pharmacol Exp Ther; 2010 Feb; 332(2):364-70. PubMed ID: 19846589
[TBL] [Abstract][Full Text] [Related]
16. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
[TBL] [Abstract][Full Text] [Related]
17. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
18. AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
Bielarczyk H; Jankowska-Kulawy A; Höfling C; Ronowska A; Gul-Hinc S; Roßner S; Schliebs R; Pawelczyk T; Szutowicz A
J Alzheimers Dis; 2015; 48(4):1083-94. PubMed ID: 26402099
[TBL] [Abstract][Full Text] [Related]
19. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
[TBL] [Abstract][Full Text] [Related]
20. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
